Mechanisms of cancer metastasis

The group "Mechanisms of tumor metastasis" is currently composed by the PI plus another 4-5 researchers with temporary or training contracts. Since joining the CIB, our group has consolidated a solid experience in the identification and development of new biomarkers and useful therapeutic targets for colorectal cancer (CRC). A large number of proteins relevant to the progression and metastasis of CRC have been characterized, including cadherin 17, IL13Rα2, PAUF and SOSTDC1, and new therapeutic strategies based on these objectives have been developed. Metastasis is responsible for more than 90% of deaths associated with cancer patients. Therefore, the study of metastasis is absolutely essential to reduce the suffering associated with cancer. The laboratory participates in an active technology transfer in the fields of health and biotechnology. Different therapeutic peptides and antibodies have been patented and licensed.